Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer
Clinical trial NCT03511378 · COMPLETED
Trial details
- NCT number
- NCT03511378
- Sponsor
- Lupin Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-06
- Primary completion
- 2019-01-09
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.